-
1
-
-
39049153587
-
Identification of TOMM34, which shows elevated expression in the majority of human colon cancers, as a novel drug target
-
Shimokawa T, Matsushima S, Tsunoda T, Tahara H, Nakamura Y and Furukawa Y: Identification of TOMM34, which shows elevated expression in the majority of human colon cancers, as a novel drug target. Int J Oncol 29: 381-386, 2006.
-
(2006)
Int J Oncol
, vol.29
, pp. 381-386
-
-
Shimokawa, T.1
Matsushima, S.2
Tsunoda, T.3
Tahara, H.4
Nakamura, Y.5
Furukawa, Y.6
-
2
-
-
0037071875
-
Molecular diagnosis of colorectal tumors by expression profiles of 50 genes expressed differentially in adenomas and carcinomas
-
DOI 10.1038/sj.onc.1205518
-
Lin YM, Furukawa Y, Tsunoda T, Yue CT, Yang KC and Nakamura Y: Molecular diagnosis of colorectal tumors by expression profiles of 50 genes expressed differentially in adenomas and carcinomas. Oncogene 21: 4120-4128, 2002. (Pubitemid 34712879)
-
(2002)
Oncogene
, vol.21
, Issue.26
, pp. 4120-4128
-
-
Lin, Y.-M.1
Furukawa, Y.2
Tsunoda, T.3
Yue, C.-T.4
Yang, K.-C.5
Nakamura, Y.6
-
3
-
-
11144231906
-
A novel oncoprotein RNF43 functions in an autocrine manner in colorectal cancer
-
Yagyu R, Furukawa Y, Lin YM, Shimokawa T, Yamamura T and Nakamura Y A novel oncoprotein RNF43 functions in an autocrine manner in colorectal cancer. Int J Oncol 25: 1343-1348, 2004
-
(2004)
Int J Oncol
, vol.25
, pp. 1343-1348
-
-
Yagyu, R.1
Furukawa, Y.2
Lin, Y.M.3
Shimokawa, T.4
Yamamura, T.5
Nakamura, Y.6
-
4
-
-
0032549799
-
Neuropilin-1 is expressed by endothelial and tumor cells as an isoform- specific receptor for vascular endothelial growth factor
-
DOI 10.1016/S0092-8674(00)81402-6
-
Soker S, Takashima S, Miao HQ, Neufield G and Klagsbrun M: Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell 92: 735-745, 1998. (Pubitemid 28155313)
-
(1998)
Cell
, vol.92
, Issue.6
, pp. 735-745
-
-
Soker, S.1
Takashima, S.2
Miao, H.Q.3
Neufeld, G.4
Klagsbrun, M.5
-
5
-
-
0036913333
-
A DNA vaccine against VEGF receptor 2 prevents effective angiogenesis and inhibits tumor growth
-
DOI 10.1038/nm794
-
Niethammer AG, Xiang R, Becker JC, Wodrich H, Pertl U, Karsten G, Eliceiri BP and Reisfield RA: A DNA vaccine against VEGF receptor 2 prevents effective angiogenesis and inhibits tumor growth. Nat Med 8: 1369-1375, 2002. (Pubitemid 36019421)
-
(2002)
Nature Medicine
, vol.8
, Issue.12
, pp. 1369-1375
-
-
Niethammer, A.G.1
Xiang, R.2
Becker, J.C.3
Wodrich, H.4
Pertl, U.5
Karsten, G.6
Eliceir, B.P.7
Reisfeld, R.A.8
-
6
-
-
0037124333
-
Active immunization against the vascular endothelial growth factor receptor flk1 inhibits tumor angiogenesis and metastasis
-
DOI 10.1084/jem.20020072
-
Li Y, Wang MN, Li H, King KD, Bassi R, Sun H, Santiago A, Hooper AT, Bohlen P and Hicklin DJ: Active immunization against the vascular endothelial growth factor receptor flk1 inhibits tumor angiogenesis and metastasis. J Exp Med 195: 1575-1584, 2002. (Pubitemid 34666071)
-
(2002)
Journal of Experimental Medicine
, vol.195
, Issue.12
, pp. 1575-1584
-
-
Li, Y.1
Wang, M.-N.2
Li, H.3
King, K.D.4
Bassi, R.5
Sun, H.6
Santiago, A.7
Hooper, A.T.8
Bohlen, P.9
Hicklin, D.J.10
-
7
-
-
19644378474
-
Rationale for antiangiogenic cancer therapy with vaccination using epitope peptides derived from human vascular endothelial growth factor receptor 2
-
DOI 10.1158/0008-5472.CAN-04-3759
-
Wada S, Tsunoda T, Baba T, Primus FJ, Kuwano H, Shibuya M and Tahara H: Rationale for antiangiogenic cancer therapy with vaccination using epitope peptides derived from human vascular endothelial growth factor receptor 2. Cancer Res 65: 4939-4946, 2005 (Pubitemid 40740834)
-
(2005)
Cancer Research
, vol.65
, Issue.11
, pp. 4939-4946
-
-
Wada, S.1
Tsunoda, T.2
Baba, T.3
Primus, F.J.4
Kuwano, H.5
Shibuya, M.6
Tahara, H.7
-
8
-
-
0036731818
-
Multicenter phase III study of uracil/tegafur and oral leucovorin versus fluorouracil and leucovorin in patients with previously untreated metastatic colorectal cancer
-
DOI 10.1200/JCO.2002.04.123
-
Douillard JY, Hoff PM, Skillings JR, Eisenberg P, Davidson N, Harper P, Vincent MD, Lembersky BC, Thompson S, Maniero A and Benner SE: Multicenter phase III study of uracil/tegafur and oral leucovorin versus fluorouracil and leucovorin in patients with previously untreated metastatic colorectal cancer. J Clin Oncol 20: 3605-3616, 2002. (Pubitemid 34983220)
-
(2002)
Journal of Clinical Oncology
, vol.20
, Issue.17
, pp. 3605-3616
-
-
Douillard, J.-Y.1
Hoff, P.M.2
Skillings, J.R.3
Eisenberg, P.4
Davidson, N.5
Harper, P.6
Vincent, M.D.7
Lembersky, B.C.8
Thompson, S.9
Maniero, A.10
Benner, S.E.11
-
9
-
-
0036727089
-
Randomized comparative study of tegafur/uracil and oral leucovorin versus parenteral fluorouracil and leucovorin in patients with previously untreated metastatic colorectal cancer
-
DOI 10.1200/JCO.2002.10.129
-
Carmichael J, Popiela T, Radstone D, Falk S, Borner M, Oza A, Skovsgaard T, Munier S and Martin C: Randomized comparative study of tegafur/uracil and oral leucovorin versus parenteral fluorouracil and leucovorin in patients with previously untreated metastatic colorectal cancer. J Clin Oncol 20: 3617-3627, 2002. (Pubitemid 34983221)
-
(2002)
Journal of Clinical Oncology
, vol.20
, Issue.17
, pp. 3617-3627
-
-
Carmichael, J.1
Popiela, T.2
Radstone, D.3
Falk, S.4
Borner, M.5
Oza, A.6
Skovsgaard, T.7
Munier, S.8
Martin, C.9
-
10
-
-
0034594628
-
New guidelines to evaluate the response to treatment in solid tumors
-
Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, Verweij J, Van Glabbeke M, van Oosterom AT, Christian MC and Gwyther SG: New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92: 205-216, 2000. (Pubitemid 30099779)
-
(2000)
Journal of the National Cancer Institute
, vol.92
, Issue.3
, pp. 205-216
-
-
Therasse, P.1
Arbuck, S.G.2
Eisenhauer, E.A.3
Wanders, J.4
Kaplan, R.S.5
Rubinstein, L.6
Verweij, J.7
Van Glabbeke, M.8
Van Oosterom, A.T.9
Christian, M.C.10
Gwyther, S.G.11
-
11
-
-
0034880680
-
Dendritic cell vaccination with MAGE peptide is a novel therapeutic approach for gastrointestinal carcinomas
-
Sadanaga N, Nagashima H, Mashino K, Tahara K, Yamaguchi H, Ohta M, Fujie T, Tanaka F, Inoue H, Takesako K, Akiyoshi T and Mori M: Dendritic cell vaccination with MAGE peptide is a novel therapeutic approach for gastrointestinal carcinomas. Clin Cancer Res 7: 2277-2284, 2001. (Pubitemid 32751625)
-
(2001)
Clinical Cancer Research
, vol.7
, Issue.8
, pp. 2277-2284
-
-
Sadanaga, N.1
Nagashima, H.2
Mashino, K.3
Tahara, K.4
Yamaguchi, H.5
Ohta, M.6
Fujie, T.7
Tanaka, F.8
Inoue, H.9
Takesako, K.10
Akiyoshi, T.11
Mori, M.12
-
12
-
-
33744815600
-
Clinical and immunologic responses to active specific cancer vaccines in human colorectal cancer
-
DOI 10.1158/1078-0432.CCR-05-2788
-
Nagorsen D and Thiel E Clinical and immunologic responses to active specific cancer vaccines in human colorectal cancer. Clin Cancer Res 12: 3064-3069, 2006. (Pubitemid 43837352)
-
(2006)
Clinical Cancer Research
, vol.12
, Issue.10
, pp. 3064-3069
-
-
Nagorsen, D.1
Thiel, E.2
-
13
-
-
4644324025
-
Cancer immunotherapy: Moving beyond current vaccines
-
DOI 10.1038/nm1100
-
Rosenberg SA, Yang JC and Restifo NP: Cancer immunotherapy: moving beyond current vaccines. Nat Med 10: 909-915, 2004 (Pubitemid 39273730)
-
(2004)
Nature Medicine
, vol.10
, Issue.9
, pp. 909-915
-
-
Rosenberg, S.A.1
Yang, J.C.2
Restifo, N.P.3
-
14
-
-
67650648498
-
Vaccination with multiple peptides derived from novel cancer-testis antigens can induce specific T-cell responses and clinical responses in advanced esophageal cancer
-
Kono K, Mizukami Y, Daigo Y, Takano A, Masuda K, Yoshida K, Tsunoda T, Kawaguchi Y, Nakamura Y and Fujii H: Vaccination with multiple peptides derived from novel cancer-testis antigens can induce specific T-cell responses and clinical responses in advanced esophageal cancer. Cancer Sci 100: 1502-1509, 2009
-
(2009)
Cancer Sci
, vol.100
, pp. 1502-1509
-
-
Kono, K.1
Mizukami, Y.2
Daigo, Y.3
Takano, A.4
Masuda, K.5
Yoshida, K.6
Tsunoda, T.7
Kawaguchi, Y.8
Nakamura, Y.9
Fujii, H.10
-
15
-
-
33644789357
-
Chemo-immunotherapy of metastatic colorectal carcinoma with gemcitabine plus FOLFOX 4 followed by subcutaneous granulocyte macrophage colony-stimulating factor and interleukin-2 induces strong immunologic and antitumor activity in metastatic colon cancer patients
-
DOI 10.1200/JCO.2005.12.147
-
Correale P, Cusi MG, Tsang KY, Del Vecchio MT, Marsili S, Placa ML, Intrivici C, Aquino A, Micheli L, Nencini C, Ferrari F, Giorgi G, Bonmassar E and Francini G: Chemo-immunotherapy of metastatic colorectal carcinoma with gemcitabine plus FOLFOX 4 followed by subcutaneous granulocyte macrophage colony-stimulating factor and interleukin-2 induces strong immunologic and antitumor activity in metastatic colon cancer patients. J Clin Oncol 23: 8950-8958, 2005 (Pubitemid 46211480)
-
(2005)
Journal of Clinical Oncology
, vol.23
, Issue.35
, pp. 8950-8958
-
-
Correale, P.1
Cusi, M.G.2
Tsang, K.Y.3
Del Vecchio, M.T.4
Marsili, S.5
La Placa, M.6
Intrivici, C.7
Aquino, A.8
Micheli, L.9
Nencini, C.10
Ferrari, F.11
Giorgi, G.12
Bonmassar, E.13
Francini, G.14
-
16
-
-
0037457485
-
Treatment of colon and breast carcinoma cells with 5-fluorouracil enhances expression of carcinoembryonic antigen and susceptibility to HLA-A(*)02.01 restricted, CEA-peptide-specific Cytotoxic T cells in vitro
-
DOI 10.1002/ijc.10969
-
*)02.01 restricted, CEA-peptide-specific cytotoxic T cells in vitro. Int J Cancer 104: 437-445, 2003. (Pubitemid 36323913)
-
(2003)
International Journal of Cancer
, vol.104
, Issue.4
, pp. 437-445
-
-
Correale, P.1
Aquino, A.2
Giuliani, A.3
Pellegrini, M.4
Micheli, L.5
Cusi, M.G.6
Nencini, C.7
Petrioli, R.8
Prete, S.9
De Vecchis, L.10
Turriziani, M.11
Giorgi, G.12
Bonmassar, E.13
Francini, G.14
-
17
-
-
21844463061
-
Chemosensitization of pancreatic carcinoma cells to enhance T cell-mediated cytotoxicity induced by tumor lysate-pulsed dendritic cells
-
Dauer M, Herten J, Bauer C, Renner F, Schad K, Schnurr M, Endres S and Eigler A: Chemosensitization of pancreatic carcinoma cells to enhance T cell-mediated cytotoxicity induced by tumor lysate-pulsed dendritic cells. J Immunother 28: 332-342, 2005 (Pubitemid 40962326)
-
(2005)
Journal of Immunotherapy
, vol.28
, Issue.4
, pp. 332-342
-
-
Dauer, M.1
Herten, J.2
Bauer, C.3
Renner, F.4
Schad, K.5
Schnurr, M.6
Endres, S.7
Eigler, A.8
-
18
-
-
23244464772
-
Dendritic cell-mediated cross-presentation of antigens derived from colon carcinoma cells exposed to a highly cytotoxic multidrug regimen with gemcitabine, oxaliplatin, 5-fluorouracil, and leucovorin, elicits a powerful human antigen-specific CTL response with antitumor activity in vitro
-
Correale P, Cusi MG, Del Vecchio MT, Aquino A, Prete SP, Tsang KY, Micheli L, Nencini C, La Placa M, Montagnani F, Terrosi C, Caraglia M, Formica V, Giorgi G, Bonmassar E and Francini G: Dendritic cell-mediated cross-presentation of antigens derived from colon carcinoma cells exposed to a highly cytotoxic multidrug regimen with gemcitabine, oxali-platin, 5-fluorouracil, and leucovorin, elicits a powerful human antigen-specific CTL response with antitumor activity in vitro. J Immunol 175: 820-828, 2005 (Pubitemid 41094964)
-
(2005)
Journal of Immunology
, vol.175
, Issue.2
, pp. 820-828
-
-
Correale, P.1
Cusi, M.G.2
Del Vecchio, M.T.3
Aquino, A.4
Prete, S.5
Tsang, K.Y.6
Micheli, L.7
Nencini, C.8
La Placa, M.9
Montagnani, F.10
Terrosi, C.11
Caraglia, M.12
Formica, V.13
Giorgi, G.14
Bonmassar, E.15
Francini, G.16
-
19
-
-
34249879033
-
Immunological evaluation of personalized peptide vaccination in combination with a 5-fluorouracil derivative (TS-1) for advanced gastric or colorectal carcinoma patients
-
DOI 10.1111/j.1349-7006.2007.00498.x
-
Sato Y, Fujiwara T, Mine T, Shomura H, Homma S, Maeda Y, Tokunaga N, Ikeda Y, Ishihara Y, Yamada A, Tanaka N, Itoh K, Harada M and Todo S: Immunological evaluation of personalized peptide vaccination in combination with a 5-fluorouracil derivative (TS-1) for advanced gastric or colorectal carcinoma patients. Cancer Sci 98: 1113-1119, 2007 (Pubitemid 46865399)
-
(2007)
Cancer Science
, vol.98
, Issue.7
, pp. 1113-1119
-
-
Sato, Y.1
Fujiwara, T.2
Mine, T.3
Shomura, H.4
Homma, S.5
Maeda, Y.6
Tokunaga, N.7
Ikeda, Y.8
Ishihara, Y.9
Yamada, A.10
Tanaka, N.11
Itoh, K.12
Harada, M.13
Todo, S.14
-
20
-
-
26944455210
-
5-Fluorouracil-based chemotherapy enhances the antitumor activity of a thymidylate synthase-directed polyepitopic peptide vaccine
-
DOI 10.1093/jnci/dji188
-
Correale P, Del Vecchio MT, Di Genova G, Savellini GG, La Placa M, Terrosi C, Vestri M, Urso R, Lemonnier F, Aquino A, Bonmassar E, Giorgi G, Francini G and Cusi MG: 5-Fluorouracil-based chemotherapy enhances the antitumor activity of a thymidylate synthase-directed polyepitopic peptide vaccine. J Natl Cancer Inst 97 1437-1445, 2005. (Pubitemid 41520079)
-
(2005)
Journal of the National Cancer Institute
, vol.97
, Issue.19
, pp. 1437-1445
-
-
Correale, P.1
Del Vecchio, M.T.2
Di Genova, G.3
Savellini, G.G.4
La Placa, M.5
Terrosi, C.6
Vestri, M.7
Urso, R.8
Lemonnier, F.9
Aquino, A.10
Bonmassar, E.11
Giorgi, G.12
Francini, G.13
Cusi, M.G.14
-
21
-
-
23844514389
-
Phase I/II combined chemoimmunotherapy with carcinoembryonic antigen-derived HLA-A2-restricted CAP-1 peptide and irinotecan, 5-fluorouracil, and leucovorin in patients with primary metastatic colorectal cancer
-
DOI 10.1158/1078-0432.CCR-05-0018
-
Weihrauch MR, Ansén S, Jurkiewicz E, Geisen C, Xia Z, Anderson KS, Gracien E, Schmidt M, Wittig B, Diehl V, Wolf J, Bohlen H and Nadler LM: Phase I/II combined chemoimmunotherapy with carcinoembryonic antigen-derived HLA-A2-restricted CAP-1 peptide and irinotecan, 5-fluorouracil, and leucovorin in patients with primary metastatic colorectal cancer. Clin Cancer Res 11: 5993-6001, 2005. (Pubitemid 41170331)
-
(2005)
Clinical Cancer Research
, vol.11
, Issue.16
, pp. 5993-6001
-
-
Weihrauch, M.R.1
Arisen, S.2
Jurkiewicz, E.3
Geisen, C.4
Xia, Z.5
Anderson, K.S.6
Gracien, E.7
Schmidt, M.8
Wittig, B.9
Diehl, V.10
Wolf, J.11
Bohlen, H.12
Nadler, L.M.13
-
22
-
-
34547652648
-
Vaccination of colorectal cancer patients with modified vaccinia ankara encoding the tumor antigen 5T4 (TroVax) given alongside chemotherapy induces potent immune responses
-
DOI 10.1158/1078-0432.CCR-07-0704
-
Harrop R, Drury N, Shingler W, Chikoti P, Redchenko I, Carroll MW, Kingsman SM, Naylor S, Melcher A, Nicholls J, Wassan H, Habib N and Anthoney A: Vaccination of colorectal cancer patients with modified vaccinia Ankara encoding the tumor antigen 5T4 (TroVax) given alongside chemotherapy induces potent immune responses. Clin Cancer Res 13: 4487-4494, 2007. (Pubitemid 47219718)
-
(2007)
Clinical Cancer Research
, vol.13
, Issue.15
, pp. 4487-4494
-
-
Harrop, R.1
Drury, N.2
Shingler, W.3
Chikoti, P.4
Redchenko, I.5
Carroll, M.W.6
Kingsman, S.M.7
Naylor, S.8
Melcher, A.9
Nicholls, J.10
Wassan, H.11
Habib, N.12
Anthoney, A.13
-
23
-
-
0029623185
-
Restoration of interleukin-2 production in tumor-bearing rats through reducing tumor-derived transforming growth factor β by treatment with bleomycin
-
DOI 10.1007/s002620050239
-
Yuan L, Kuramitsu Y, Li Y, Kobayashi M and Hosokawa M: Restoration of interleukin-2 production in tumor-bearing rats through reducing tumor-derived transforming growth factor beta by treatment with bleomycin. Cancer Immunol Immunother 41: 355-362, 1995 (Pubitemid 26041719)
-
(1995)
Cancer Immunology Immunotherapy
, vol.41
, Issue.6
, pp. 355-362
-
-
Yuan, L.1
Kuramitsu, Y.2
Li, Y.3
Kobayashi, M.4
Hosokawa, M.5
-
24
-
-
0035104753
-
5-Fluorouracil induced Fas upregulation associated with apoptosis in liver metastases of colorectal cancer patients
-
DOI 10.1023/A:1008331525368
-
Backus HH, Dukers DF, van Groeningen CJ, Vos W, Bloemena E, Wouters D, van Riel JM, Smid K, Giaccone G, Pinedo HM and Peters GJ: 5-Fluorouracil induced Fas upregulation is associated with apoptosis in liver metastases of colorectal cancer patients. Ann Oncol 12: 209-216, 2001. (Pubitemid 32223870)
-
(2001)
Annals of Oncology
, vol.12
, Issue.2
, pp. 209-216
-
-
Backus, H.H.J.1
Dukers, D.F.2
Van Groeningen, C.J.3
Vos, W.4
Bloemena, E.5
Wouters, D.6
Van Riel, J.M.G.H.7
Smid, K.8
Giaccone, G.9
Pinedo, H.M.10
Peters, G.J.11
-
25
-
-
10744222555
-
Immunological evaluation of peptide vaccination for patients with gastric cancer based on pre-existing cellular response to peptide
-
DOI 10.1111/j.1349-7006.2003.tb01522.x
-
Sato Y, Shomura H, Maeda Y, Mine T, Une Y, Akasaka Y, Kondo M, Takahashi S, Shinohara T, Katagiri K, Sato M, Okada S, Matsui K, Yamada A, Yamana H, Itoh K and Todo S: Immunological evaluation of peptide vaccination for patients with gastric cancer based on pre-existing cellular response to peptide. Cancer Sci 94: 802-808, 2003. (Pubitemid 37258779)
-
(2003)
Cancer Science
, vol.94
, Issue.9
, pp. 802-808
-
-
Sato, Y.1
Shomura, H.2
Maeda, Y.3
Mine, T.4
Une, Y.5
Akasaka, Y.6
Kondo, M.7
Takahashi, S.8
Shinohara, T.9
Katagiri, K.10
Sato, M.11
Okada, S.12
Matsui, K.13
Yamada, A.14
Yamana, H.15
Itoh, K.16
Todo, S.17
|